Advanced Research in Mitochondrial Medicine and Nanomedicine

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 128

Special Issue Editor


E-Mail Website
Guest Editor
Department of Physiology, Medical University of Gdańsk, 80-211 Gdańsk, Poland
Interests: anticancer agents; mitochondria; cancer metabolism; nanoparticles; ER stress; natural compounds; synthetic derivatives; antimicrobial agents; targeted therapy

Special Issue Information

Dear Colleagues,

Mitochondria-targeted medicine is an emerging frontier in precision therapy, aiming to improve treatment efficacy and specificity by directing bioactive compounds to these vital organelles. Such targeted approaches enable lower therapeutic doses, reduce systemic toxicity, and help overcome drug resistance, making them highly relevant for the treatment of complex and chronic diseases.

Mitochondria are central regulators of apoptosis, ATP production, redox balance, mitophagy, and cellular homeostasis. Their dysfunction is implicated in a broad range of conditions, including neurodegenerative disorders (e.g., Alzheimer’s and Parkinson’s diseases), cancer, metabolic syndromes, and cardiovascular pathologies. In these contexts, precise mitochondrial targeting has the potential to modulate disease pathways at their origin. Nanomedicine offers transformative opportunities to achieve this goal, particularly through the development of advanced delivery systems capable of selectively accumulating in mitochondria. Such systems are paving the way for innovative therapies that integrate mitochondrial biology with cutting-edge nanotechnology.

This Special Issue welcomes original research and comprehensive reviews that advance the understanding of mitochondrial medicine and its intersection with nanomedicine. We invite contributions that highlight novel therapeutic targets, innovative delivery platforms, and translational strategies that can bring mitochondria-targeted medicine closer to clinical application.

Dr. Agnieszka Pyrczak-Felczykowska
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanomedicine
  • nanoparticles
  • drug delivery
  • mitochondria
  • cancer
  • neurodegenerative disease
  • metabolism
  • targeted therapy
  • mitochondrial function
  • bioactive compounds

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop